» Authors » Lucia Lara de la Torre

Lucia Lara de la Torre

Explore the profile of Lucia Lara de la Torre including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 3
Citations 21
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinenaite E, Lecoq I, Aaboe-Jorgensen M, Ahmad S, Perez-Penco M, Glockner H, et al.
J Immunother Cancer . 2025 Jan; 13(1). PMID: 39880485
Background: Arginase-1 (Arg1) expressing tumor-associated macrophages (TAMs) may create an immune-suppressive tumor microenvironment (TME), which is a significant challenge for cancer immunotherapy. We previously reported the existence of Arg1-specific memory...
2.
Perez-Penco M, Byrdal M, Lara de la Torre L, Ballester M, Khan S, Siersbaek M, et al.
Cell Mol Immunol . 2024 Dec; 22(1):111-126. PMID: 39653766
Although interleukin (IL)-6 is considered immunosuppressive and tumor-promoting, emerging evidence suggests that it may support antitumor immunity. While combining immune checkpoint inhibitors (ICIs) and radiotherapy in patients with pancreatic cancer...
3.
Perez-Penco M, Lara de la Torre L, Lecoq I, Martinenaite E, Andersen M
J Immunother Cancer . 2024 Feb; 12(2). PMID: 38417917
The tumor microenvironment (TME) of pancreatic cancer is highly immunosuppressive. We recently developed a transforming growth factor (TGF)β-based immune modulatory vaccine that controlled tumor growth in a murine model of...
4.
Perez-Penco M, Weis-Banke S, Schina A, Siersbaek M, Hubbe M, Jorgensen M, et al.
J Immunother Cancer . 2023 Jan; 10(12). PMID: 36600556
Background: Pancreatic ductal adenocarcinoma (PDAC) is associated with very poor survival, making it the third and fourth leading cause of all cancer-related deaths in the USA and European Union, respectively....